Regulatory Advocacy

Regulatory Advocacy

NKF policy staff routinely comment on regulatory proposals and issue policy statements on important topics that affect kidney patients.

Group of Kidney Advocates gathered in Washington DC

Recent Statements

Our most recent statements are listed below but please check out our blog for the latest news.
Icon of magnifying glass

Funding for Innovation, Prevention, and Research

By focusing on funding for early detection, patient-centric care, prevention, and research advancements, we aim to improve the lives of individuals affected by and contribute to the national fight against Chronic Kidney Disease (CKD).

Icon of megaphone

CKD Awareness and Detection

We must implement regulations and policies that empower individuals, healthcare professionals, and communities to take proactive measures in the fight against CKD.

Icon of hands with money depicting affordability

Access and Affordability

We take a comprehensive policy approach that prioritizes access and affordability for kidney disease patients. We must ensure that all individuals, regardless of their socioeconomic status, can receive the necessary treatment, get expedited access to emerging therapeutics, and manage their condition effectively through value-based payment reform.

Icon depicting equity


NKF endeavors to create a future where every individual, regardless of their background or circumstances, can achieve optimal kidney health and well-being. We are committed to developing and implementing policies that eliminate barriers, empower communities, and ensure equitable access to prevention, diagnosis, treatment, and support services across the kidney care continuum.

Icon of a kidney failure

Kidney Failure

NKF is committed to advocating for patient-centered care, promoting equitable access to treatments, and fostering continuous improvement in the management and outcomes of ESRD. Our efforts focus on treatment innovation, dialysis modality choice, and improved quality of life.


We strive to shape policies that optimize access, equity, and quality in kidney transplantation. We endeavor to improve the lives of individuals with end-stage-renal disease (ESRD) by enhancing the availability and success of kidney transplantation.